Almirall, S.A. (BME:ALM)
10.68
-0.12 (-1.11%)
May 13, 2025, 10:45 AM CET
Almirall Revenue
Almirall had revenue of 286.10M EUR in the quarter ending March 31, 2025, with 14.99% growth. This brings the company's revenue in the last twelve months to 1.03B, up 12.33% year-over-year. In the year 2024, Almirall had annual revenue of 990.63M with 10.22% growth.
Revenue (ttm)
1.03B
Revenue Growth
+12.33%
P/S Ratio
2.33
Revenue / Employee
488.96K
Employees
2,026
Market Cap
2.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 990.63M | 91.84M | 10.22% |
Dec 31, 2023 | 898.79M | 20.28M | 2.31% |
Dec 31, 2022 | 878.51M | 42.01M | 5.02% |
Dec 31, 2021 | 836.50M | 22.01M | 2.70% |
Dec 31, 2020 | 814.49M | -96.17M | -10.56% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.21B |
Laboratorios Farmaceuticos Rovi | 767.47M |
Faes Farma | 524.02M |
Pharma Mar | 175.75M |
Clínica Baviera | 265.72M |
Laboratorio Reig Jofre | 338.90M |
Atrys Health | 218.10M |
Oryzon Genomics | 7.36M |
Almirall News
- 22 hours ago - Almirall, S.A. reports Q1 results - Seeking Alpha
- 2 months ago - Almirall, S.A. reports FY results - Seeking Alpha
- 2 months ago - Almiralll, S.A. (LBTSF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Almirall, S.A. (LBTSF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Almirall, S.A. reports nine-month 2024 results; reaffirms FY24 outlook - Seeking Alpha
- 10 months ago - Almirall, S.A. (LBTSF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Almirall, S.A. (LBTSF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio - Business Wire